Literature DB >> 25710361

Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year.

W E Moody1, N C Edwards, C D Chue, R J Taylor, C J Ferro, J N Townend, R P Steeds.   

Abstract

OBJECTIVE: Variability in the measurement of left ventricular (LV) parameters in cardiovascular imaging has typically been assessed over a short time interval, but clinicians most commonly compare results from studies performed a year apart. To account for variation in technical, procedural and biological factors over this time frame, we quantified the within-subject changes in LV volumes, LV mass (LVM) and LV ejection fraction (EF) in a well-defined cohort of healthy adults at 12 months.
METHODS: Cardiac MR (CMR) was performed in 42 healthy control subjects at baseline and at 1 year (1.5 T Magnetom® Avanto; Siemens Healthcare, Erlangen, Germany). Analysis of steady-state free precession images was performed manually offline (Argus software; Siemens Healthcare) for assessment of LV volumes, LVM and EF by a single blinded observer. A random subset of 10 participants also underwent repeat imaging within 7 days to determine short-term interstudy reproducibility.
RESULTS: There were no significant changes in any LV parameter on repeat CMR at 12 months. The short-term interstudy biases were not significantly different from the long-term changes observed at 1 year. The smallest detectable change (SDC) for LVEF, end-diastolic volume, end-systolic volume and LVM that could be recognized with 95% confidence were 6%, 13 ml, 7 ml and 6 g, respectively.
CONCLUSION: The variability in CMR-derived LV measures arising from technical, procedural and biological factors remains minimal at 12 months. Thus, for patients undergoing repeat annual assessment by CMR, even small differences in LV function, size and LVM (which are greater than the SDC) may be attributed to disease-related factors. ADVANCES IN KNOWLEDGE: The reproducibility and reliability of CMR data at 12 months is excellent allowing clinicians to be confident that even small changes in LV structure and function over this time frame are real.

Entities:  

Mesh:

Year:  2015        PMID: 25710361      PMCID: PMC4628481          DOI: 10.1259/bjr.20140831

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  12 in total

Review 1.  Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM.

Authors:  Joseph P Weir
Journal:  J Strength Cond Res       Date:  2005-02       Impact factor: 3.775

2.  Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging.

Authors:  Lucy E Hudsmith; Steffen E Petersen; Jane M Francis; Matthew D Robson; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2005       Impact factor: 5.364

3.  Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance.

Authors:  A M Maceira; S K Prasad; M Khan; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2006       Impact factor: 5.364

Review 4.  ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.

Authors:  Robert C Hendel; Manesh R Patel; Christopher M Kramer; Michael Poon; Robert C Hendel; James C Carr; Nancy A Gerstad; Linda D Gillam; John McB Hodgson; Raymond J Kim; Christopher M Kramer; John R Lesser; Edward T Martin; Joseph V Messer; Rita F Redberg; Geoffrey D Rubin; John S Rumsfeld; Allen J Taylor; Wm Guy Weigold; Pamela K Woodard; Ralph G Brindis; Robert C Hendel; Pamela S Douglas; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel
Journal:  J Am Coll Cardiol       Date:  2006-10-03       Impact factor: 24.094

Review 5.  Serial myocardial perfusion imaging: defining a significant change and targeting management decisions.

Authors:  Ami E Iskandrian; Fadi G Hage; Leslee J Shaw; John J Mahmarian; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2014-01

6.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

Authors:  Frank Grothues; Gillian C Smith; James C C Moon; Nicholas G Bellenger; Peter Collins; Helmut U Klein; Dudley J Pennell
Journal:  Am J Cardiol       Date:  2002-07-01       Impact factor: 2.778

7.  Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Susan Cheng; Verônica R S Fernandes; David A Bluemke; Robyn L McClelland; Richard A Kronmal; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-26       Impact factor: 7.792

8.  Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease.

Authors:  Sohrab Fratz; Taylor Chung; Gerald F Greil; Margaret M Samyn; Andrew M Taylor; Emanuela R Valsangiacomo Buechel; Shi-Joon Yoo; Andrew J Powell
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-13       Impact factor: 5.364

9.  The case for using the repeatability coefficient when calculating test-retest reliability.

Authors:  Sharmila Vaz; Torbjörn Falkmer; Anne Elizabeth Passmore; Richard Parsons; Pantelis Andreou
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.

Authors:  William E Moody; Laurie A Tomlinson; Charles J Ferro; Richard P Steeds; Patrick B Mark; Daniel Zehnder; Charles R Tomson; John R Cockcroft; Ian B Wilkinson; Jonathan N Townend
Journal:  Am Heart J       Date:  2013-11-06       Impact factor: 4.749

View more
  12 in total

Review 1.  Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic Criteria.

Authors:  Anthony H Masso; Carlo Uribe; James T Willerson; Benjamin Y Cheong; Barry R Davis
Journal:  Tex Heart Inst J       Date:  2020-06-01

2.  Diastolic dysfunction evaluated by cardiac magnetic resonance: the value of the combined assessment of atrial and ventricular function.

Authors:  Giovanni Donato Aquaro; Fausto Pizzino; Anna Terrizzi; Scipione Carerj; Bijoy K Khandheria; Gianluca Di Bella
Journal:  Eur Radiol       Date:  2018-08-20       Impact factor: 5.315

3.  Free-breathing cine imaging with motion-corrected reconstruction at 3T using SPiral Acquisition with Respiratory correction and Cardiac Self-gating (SPARCS).

Authors:  Ruixi Zhou; Yang Yang; Roshin C Mathew; John P Mugler; Daniel S Weller; Christopher M Kramer; Abdul Haseeb Ahmed; Mathews Jacob; Michael Salerno
Journal:  Magn Reson Med       Date:  2019-04-21       Impact factor: 4.668

4.  Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial.

Authors:  Nicola C Edwards; Anna M Price; Samir Mehta; Thomas F Hiemstra; Amreen Kaur; Peter J Greasley; David J Webb; Neeraj Dhaun; Iain M MacIntyre; Tariq Farrah; Vanessa Melville; Anna S Herrey; Gemma Slinn; Rebekah Wale; Natalie Ives; David C Wheeler; Ian Wilkinson; Richard P Steeds; Charles J Ferro; Jonathan N Townend
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-30       Impact factor: 10.614

Review 5.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

Review 6.  Cardiovascular imaging approach in pre and postoperative tetralogy of Fallot.

Authors:  Sotiria C Apostolopoulou; Athanassios Manginas; Nikolaos L Kelekis; Michel Noutsias
Journal:  BMC Cardiovasc Disord       Date:  2019-01-07       Impact factor: 2.298

Review 7.  Advanced Imaging Modalities to Monitor for Cardiotoxicity.

Authors:  Andreas Seraphim; Mark Westwood; Anish N Bhuva; Tom Crake; James C Moon; Leon J Menezes; Guy Lloyd; Arjun K Ghosh; Sarah Slater; Heather Oakervee; Charlotte H Manisty
Journal:  Curr Treat Options Oncol       Date:  2019-08-08

8.  British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab.

Authors:  Rebecca Dobson; Arjun K Ghosh; Bonnie Ky; Tom Marwick; Martin Stout; Allan Harkness; Rick Steeds; Shaun Robinson; David Oxborough; David Adlam; Susannah Stanway; Bushra Rana; Thomas Ingram; Liam Ring; Stuart Rosen; Chris Plummer; Charlotte Manisty; Mark Harbinson; Vishal Sharma; Keith Pearce; Alexander R Lyon; Daniel X Augustine
Journal:  Echo Res Pract       Date:  2021-03-31

9.  Relationship Between Left Ventricular Ejection Fraction Variation and Systemic Vascular Resistance: A Prospective Cardiovascular Magnetic Resonance Study.

Authors:  Damien Mandry; Nicolas Girerd; Zohra Lamiral; Olivier Huttin; Laura Filippetti; Emilien Micard; Marine Beaumont; Marie-Paule Bernadette Ncho Mottoh; Nathalie Pace; Faïez Zannad; Patrick Rossignol; Pierre-Yves Marie
Journal:  Front Cardiovasc Med       Date:  2021-12-24

10.  What is the minimum change in left ventricular ejection fraction, which can be measured with contrast echocardiography?

Authors:  Tan Suwatanaviroj; Weimin He; Edith Pituskin; Ian Paterson; Jonathan Choy; Harald Becher
Journal:  Echo Res Pract       Date:  2018-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.